108 related articles for article (PubMed ID: 21351453)
41. Using C60 fullerenes for photodynamic inactivation of mosquito iridescent viruses.
Rud Y; Buchatskyy L; Prylutskyy Y; Marchenko O; Senenko A; Schütze Ch; Ritter U
J Enzyme Inhib Med Chem; 2012 Aug; 27(4):614-7. PubMed ID: 21883040
[TBL] [Abstract][Full Text] [Related]
42. Challenge study of the pathogen reduction capacity of the THERAFLEX MB-Plasma technology.
Reichenberg S; Gravemann U; Sumian C; Seltsam A
Vox Sang; 2015 Aug; 109(2):129-37. PubMed ID: 25899343
[TBL] [Abstract][Full Text] [Related]
43. Synthesis and anti-hepatitis B virus activity of a novel class of thiazolylbenzimidazole derivatives.
Luo Y; Yao JP; Yang L; Feng CL; Tang W; Wang GF; Zuo JP; Lu W
Arch Pharm (Weinheim); 2011 Feb; 344(2):78-83. PubMed ID: 21290423
[TBL] [Abstract][Full Text] [Related]
44. Investigation of photosensitizing dyes for pathogen reduction in red cell suspensions.
Wagner SJ; Skripchenko A
Biotech Histochem; 2003; 78(3-4):171-7. PubMed ID: 14714880
[TBL] [Abstract][Full Text] [Related]
45. Photodynamic virus inactivation of thrombocyte concentrates by phenothiazine dyes.
Klein-Struckmeier A; Mohr H
Beitr Infusionsther Transfusionsmed; 1997; 34():43-7. PubMed ID: 9356657
[No Abstract] [Full Text] [Related]
46. Design and synthesis of novel benzimidazole derivatives as inhibitors of hepatitis B virus.
Luo Y; Yao JP; Yang L; Feng CL; Tang W; Wang GF; Zuo JP; Lu W
Bioorg Med Chem; 2010 Jul; 18(14):5048-55. PubMed ID: 20639110
[TBL] [Abstract][Full Text] [Related]
47. Photodynamic treatment of adenoviral vectors with visible light: an easy and convenient method for viral inactivation.
Schagen FH; Moor AC; Cheong SC; Cramer SJ; van Ormondt H; van der Eb AJ; Dubbelman TM; Hoeben RC
Gene Ther; 1999 May; 6(5):873-81. PubMed ID: 10505113
[TBL] [Abstract][Full Text] [Related]
48. Inactivation of parvovirus B19 in human platelet concentrates by treatment with amotosalen and ultraviolet A illumination.
Sawyer L; Hanson D; Castro G; Luckett W; Dubensky TW; Stassinopoulos A
Transfusion; 2007 Jun; 47(6):1062-70. PubMed ID: 17524098
[TBL] [Abstract][Full Text] [Related]
49. The role of DNA damage in PM2 viral inactivation by methylene blue photosensitization.
Specht KG
Photochem Photobiol; 1994 May; 59(5):506-14. PubMed ID: 8041805
[TBL] [Abstract][Full Text] [Related]
50. Differential photodynamic response of cultured cells to methylene blue and toluidine blue: role of dark redox processes.
Blázquez-Castro A; Stockert JC; Sanz-Rodríguez F; Zamarrón A; Juarranz A
Photochem Photobiol Sci; 2009 Mar; 8(3):371-6. PubMed ID: 19255678
[TBL] [Abstract][Full Text] [Related]
51. Synthesis and anti-hepatitis B virus activity of novel benzimidazole derivatives.
Li YF; Wang GF; He PL; Huang WG; Zhu FH; Gao HY; Tang W; Luo Y; Feng CL; Shi LP; Ren YD; Lu W; Zuo JP
J Med Chem; 2006 Jul; 49(15):4790-4. PubMed ID: 16854087
[TBL] [Abstract][Full Text] [Related]
52. [Virus inactivation of plasma].
Schmitt H; Mohr H; Lambrecht B; Knüver-Hopf J
Beitr Infusionsther; 1991; 28():82-91. PubMed ID: 1725665
[TBL] [Abstract][Full Text] [Related]
53. Synthesis and antimicrobial activities of novel biologically active heterocycles: 10h-phenothiazines, their ribofuranosides, and sulfone derivatives.
Dixit Y; Dixit R; Gautam N; Gautam DC
Nucleosides Nucleotides Nucleic Acids; 2009 Nov; 28(11):998-1006. PubMed ID: 20183568
[TBL] [Abstract][Full Text] [Related]
54. Mechanisms of photodynamic inactivation of herpes simplex viruses: comparison between methylene blue, light plus electricity, and hematoporhyrin plus light.
Schnipper LE; Lewin AA; Swartz M; Crumpacker CS
J Clin Invest; 1980 Feb; 65(2):432-8. PubMed ID: 6243310
[TBL] [Abstract][Full Text] [Related]
55. Methylene blue derivatives--suitable photoantimicrobials for blood product disinfection?
Wainwright M
Int J Antimicrob Agents; 2000 Dec; 16(4):381-94. PubMed ID: 11118846
[TBL] [Abstract][Full Text] [Related]
56. Infection cycle of herpes viruses after photodynamic treatment with methylene blue and light.
Müller-Breitkreutz K; Mohr H
Beitr Infusionsther Transfusionsmed; 1997; 34():37-42. PubMed ID: 9356656
[TBL] [Abstract][Full Text] [Related]
57. Synthesis, properties and photodynamic inactivation of Escherichia coli by novel cationic fullerene C60 derivatives.
Spesia MB; Milanesio ME; Durantini EN
Eur J Med Chem; 2008 Apr; 43(4):853-61. PubMed ID: 17706838
[TBL] [Abstract][Full Text] [Related]
58. Synthesis and antiviral activity against Coxsackie virus B3 of some novel benzimidazole derivatives.
Cheng J; Xie J; Luo X
Bioorg Med Chem Lett; 2005 Jan; 15(2):267-9. PubMed ID: 15603937
[TBL] [Abstract][Full Text] [Related]
59. [Viral inactivation of fresh frozen plasma].
Michel M; Zwahlen R; Brand B
Ann Med Interne (Paris); 1997; 148(4):311-4. PubMed ID: 9515098
[TBL] [Abstract][Full Text] [Related]
60. Retroviral self-inactivation in the mouse vagina induced by short DNA.
Wittmer-Elzaouk L; Jung-Shiu J; Heinrich J; Moelling K
Antiviral Res; 2009 Apr; 82(1):22-8. PubMed ID: 19189851
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
